JetSet Therapeutics LLC – Trademark Portfolio

Entity Type: 16

JetSet Therapeutics LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include JETSET MEDS. The owner is based in Margate City, NJ.

115 N. Pembroke Avenue

Margate City, NJ 08402

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

JetSet Therapeutics LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does JetSet Therapeutics LLC have?

JetSet Therapeutics LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does JetSet Therapeutics LLC file in?

JetSet Therapeutics LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are JetSet Therapeutics LLC's most well-known trademarks?

JetSet Therapeutics LLC's registered trademark portfolio includes well-known marks such as JETSET MEDS. These are among 1 currently registered trademark in the portfolio.

What is JetSet Therapeutics LLC's trademark registration success rate?

JetSet Therapeutics LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.